Free Trial

Heart Test Laboratories Q4 2023 Earnings Report

Heart Test Laboratories logo
$2.75 -0.07 (-2.48%)
As of 03:49 PM Eastern

Heart Test Laboratories EPS Results

Actual EPS
-$16.00
Consensus EPS
-$12.00
Beat/Miss
Missed by -$4.00
One Year Ago EPS
N/A

Heart Test Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Heart Test Laboratories Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Remove Ads

Heart Test Laboratories Earnings Headlines

Ascendiant Capital Markets Weighs in on HSCS Q4 Earnings
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.
See More Heart Test Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Heart Test Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heart Test Laboratories and other key companies, straight to your email.

About Heart Test Laboratories

Heart Test Laboratories (NASDAQ:HSCS), a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

View Heart Test Laboratories Profile

More Earnings Resources from MarketBeat